Z

Zosano Pharma Corp
F:0ZPN

Watchlist Manager
Zosano Pharma Corp
F:0ZPN
Watchlist
Price: 0.525 EUR Market Closed
Market Cap: 18.9m EUR

Operating Margin

-5 485.3%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5 485.3%
=
Operating Income
$-30.9m
/
Revenue
$660k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5 485.3%
=
Operating Income
€-30.9m
/
Revenue
$660k

Peer Comparison

Country Company Market Cap Operating
Margin
US
Zosano Pharma Corp
F:0ZPN
18.9m EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
210.8B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
186.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
138B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.3B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.7B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.8B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.3B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-5 485.3%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Zosano Pharma Corp
Glance View

Market Cap
18.9m EUR
Industry
Health Care

Zosano Pharma Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Fremont, California and currently employs 40 full-time employees. The company went IPO on 2015-01-27. Zosano Pharma Corporation is a clinical-stage biopharmaceutical company. The firm is focused on providing rapid systemic administration of therapeutics and other bioactive molecules to patients using its transdermal microneedle system (the System). Its System is designed to facilitate rapid drug absorption into the bloodstream, and to provide an improved pharmacokinetic (PK) profile compared to original dosage forms. The System consists of a three cm square to six cm square array of titanium microneedles approximately 200-350 microns in length, coated with a hydrophilic formulation of drug, mounted on an adhesive patch. The company is focused on development of its lead product candidate, M207, a formulation of zolmitriptan, which is used as an acute treatment for migraine. Its zolmitriptan formulation is delivered utilizing its system. M207 is designed to provide rapid absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal (GI) tract.

0ZPN Intrinsic Value
Not Available
Z
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-5 485.3%
=
Operating Income
$-30.9m
/
Revenue
$660k
How has Operating Margin changed over time?

Over the last 1 years, Zosano Pharma Corp’s Operating Margin has increased from -18 198.5% to -5 485.3%. During this period, it reached a low of -18 198.5% on Dec 31, 2020 and a high of -3 897.3% on Sep 30, 2021.

Back to Top